22-41237366-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138481.2(CHADL):c.1706G>A(p.Arg569Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000715 in 1,398,330 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138481.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHADL | NM_138481.2 | c.1706G>A | p.Arg569Gln | missense_variant | 3/6 | ENST00000216241.14 | NP_612490.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHADL | ENST00000216241.14 | c.1706G>A | p.Arg569Gln | missense_variant | 3/6 | 1 | NM_138481.2 | ENSP00000216241 | P1 | |
CHADL | ENST00000417999.5 | c.1700G>A | p.Arg567Gln | missense_variant | 2/5 | 5 | ENSP00000392046 | |||
CHADL | ENST00000455425.1 | c.197G>A | p.Arg66Gln | missense_variant | 2/4 | 2 | ENSP00000412359 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 7.15e-7 AC: 1AN: 1398330Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 689714
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2022 | The c.1706G>A (p.R569Q) alteration is located in exon 3 (coding exon 3) of the CHADL gene. This alteration results from a G to A substitution at nucleotide position 1706, causing the arginine (R) at amino acid position 569 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at